GENE ONLINE|News &
Opinion
Blog

Autoimmune Disease
Vera Therapeutics Eyes Phase 3 For Kidney Disease Candidate Following Positive Data
2023-01-04
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Vallon and GRI Bio Strike a Merger Deal, Joining Forces for Innovative NKT Cell Regulators
2022-12-14
Japan Approves AstraZeneca’s Complement Inhibitor For Rare Muscle Disorder
2022-08-26
Takeda Announces Positive Topline From Pivotal Trial For Autoimmune Disease
2022-07-25
How Single Cell Sequencing is Advancing Biomedical Research
2022-07-15
New Mitochondrial Response Pathway May Advance Treatments for Inflammatory Diseases
2022-07-14
AbbVie & Cugene Join Forces to Tackle Autoimmune Diseases
2022-05-17
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Sanofi’ Enjaymo Wins FDA Approval for Rare Autoimmune Anemia
2022-02-07
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
Mozart Therapeutics Makes Play with $55 Million Series A to Capitalize on Novel Tregs Pathway
2021-10-27
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
COVID-19: FDA Adds New Warning For a Rare Autoimmune Disorder to J&J’s Vaccine
2021-07-14
Janssen’s Multiple Sclerosis Drug Snags FDA Win after Besting Sanofi’s Blockbuster in Phase 3
2021-03-21
1 2
LATEST
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
3D Printed Brain Model Could Aid in Neurosurgery
2023-03-31
Latest Study on Neuronal Gene Expression May Shed Light on the Memory Formation Process
2023-03-30
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Scroll to Top